Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Gensia, Pfizer to collaborate on ARA-based analgesics

May 17, 1996

Dyax phage display technology receives patent protection

May 10, 1996

CEPRATE SC approvable for autologous BMT

May 10, 1996

Optex receives NIH grant to develop Catarex

May 10, 1996

Sterizone System to be evaluated in Cornell study

May 10, 1996

CR1 technology licensed to CytoTherapeutics

May 10, 1996

Gryphon, SKB to study mirror image proteins

May 10, 1996

Hyal to study agents for macular degeneration

May 10, 1996

RiboGene and Abbott collaborate on antifungal drugs

May 10, 1996

BioChem, Oncogene to investigate treatments for HCV, HIV

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...